Resilienci.ai is an Austin-based digital health company using artificial intelligence, machine learning and hyperlocal data to help people and public health agencies understand and reduce infectious-disease risk. Founded by Eric Klasson and operating as a Pandemic Insights company, it builds a free consumer mobile app paired with a web-based platform for health agencies, aiming to deliver the world's first interoperable, multi-pathogen digital health solution for outbreaks and pandemics.
Tiba Biotech is a Cambridge, Massachusetts preclinical biotech spun out of MIT and the Whitehead Institute that is building a new generation of RNA vaccines and therapeutics. Its RNABL platform swaps the fragile lipid nanoparticles behind first-generation mRNA shots for fully synthetic, biodegradable dendrimer nanoparticles that carry larger RNA payloads with less toxicity and gentler cold-chain demands. The company is applying the technology across human vaccines, cancer immunotherapy, gene editing delivery, and animal health, backed by CEPI, BARDA, the NIH, and the NCI.